Fundraising Fox

Karen Spilizewski

Investor

Managing Director at RiverVest Venture Partners

Cleveland, Ohio

FoundedVentureMed Group

About

A biomedical engineer by training, Karen Spilizewski joined RiverVest in 2008 to manage the Cleveland office and was promoted to Managing Director in 2023, focusing on identifying and evaluating early-stage medical device technologies and supporting portfolio company CEOs. She previously directed medical device business development at BioEnterprise and spent 19 years at Avery Dennison, and holds an MBA, MS, and BS from Case Western Reserve University.

Experience

  1. RiverVest Venture PartnersManaging Directorcurrent2023 β€” present
  2. RiverVest Venture PartnersVice President2008 β€” 2023Cleveland, OH and St. Louis, MO
  3. Standard Bariatrics, IncMember Board Of Directors2018 β€” 2022Cincinnati, OH
  4. BioEnterpriseVice President, Business Development2005 β€” 2020Cleveland, OH
  5. Securus Medical GroupMember Board Of Directors2011 β€” 2018Cleveland, OH
  6. Neuros Medical, Inc.Board Observer2011 β€” 2017Willoughby Hills, OH
  7. Avery DennisonBusiness Development Manager1986 β€” 2005

Education

  1. Weatherhead School of Management at Case Western Reserve UniversityMaster of Business Administration (MBA)1989 β€” 1993
  2. Case Western Reserve UniversityMaster of Science (MS), Polymer Science1984 β€” 1986
  3. Case Western Reserve UniversityBachelor of Science (BS), Biomedical/Medical Engineering1980 β€” 1984

Skills & more

ManagementStrategic Planning1Strategy1New Business Development27Venture Capital47Biomedical Engineering23Medical Devices67Due Diligence12BiotechnologyMergers & Acquisitions2Technology Transfer1Business Strategy
+12 moreCommercializationProduct DevelopmentR&DStart-upsLicensingMedical ImagingCorporate DevelopmentPrivate EquityISO 13485Business PlanningLifesciencesCross-functional Team Leadership

From Karen's professional profile.

Same school

Shared employers

Deals Β· 1

VentureMed GroupBoard seat

via RiverVest Venture Partners Β· filed Feb 2025 Β· $7.5M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at RiverVest Venture Partners